We are live on ! Find out more
PRVA icon

Privia Health

231 hedge funds and large institutions have $2.35B invested in Privia Health in 2024 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 102 increasing their positions, 64 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

198% more call options, than puts

Call options by funds: $7.97M | Put options by funds: $2.68M

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

59% more repeat investments, than reductions

Existing positions increased: 102 | Existing positions reduced: 64

8% more capital invested

Capital invested by funds: $2.18B → $2.35B (+$168M)

0.08% less ownership

Funds ownership: 100.15%100.07% (-0.08%)

1% less funds holding

Funds holding: 234231 (-3)

10% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 30

Holders
231
Holders Change
-3
Holders Change %
-1.28%
% of All Funds
3.04%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
27
Increased
102
Reduced
64
Closed
30
Calls
$7.97M
Puts
$2.68M
Net Calls
+$5.3M
Net Calls Change
+$538K

PRVA Hedge Fund Activity: Q4 2024 in Review

231 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Privia Health (PRVA) for Q4 2024, worth a combined $2.35B — up 7.7% from $2.18B a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of PRVA and 27 opened new positions — a net loss of 3 holders — while 64 trimmed existing stakes and 102 added.

The largest buyer was Riverbridge Partners, adding an estimated $19M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $32.9M.

  • 231 institutional investors held Privia Health (PRVA) as of Q4 2024, down from 234 in Q3 2024.
  • Funds reported $2.35B of Privia Health stock for Q4 2024, up 7.7% quarter-over-quarter.
  • 27 funds opened new Privia Health positions in Q4 2024 and 30 closed out, a net change of -3 holders.
  • The largest Privia Health buyer in Q4 2024 was Riverbridge Partners, an estimated $19M added.
  • The largest Privia Health seller in Q4 2024 was T. Rowe Price Investment Management, an estimated $32.9M sold.

Based on aggregated 13F filings for Q4 2024.